Cancer Vaccines
Scientists at Biotech Center discuss research in cancer vaccines
Published in Vaccine Weekly, July 2nd, 2008
New investigation results, 'Human papillomavirus type 16 L1E7 chimeric capsomeres have prophylactic and therapeutic efficacy against papillomavirus in mice,' are detailed in a study published in Molecular Cancer Therapeutics. According to a study from Beijing, People's Republic of China, "Genital human papillomavirus (HPV) infection is the primary cause of cervical cancer in women. Although the HPV recombinant L1 protein was recently licensed as an available vaccine, it has numerous shortcomings."
"New vaccination strategies should be considered. To enable the design of a prophylactic and therapeutic low-cost vaccine candidate, chimeric HPV16 L1DeltaC34E7N1-60...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Vaccine Weekly
Source: Vaccine Weekly (2008-07-02)
More Articles from Vaccine Weekly
- Anthrax Vaccines
Researchers at Food & Drug Administration target anthrax vaccines - Artificial Chromosomes
Reports outline artificial chromosomes research from Mississippi State University - Baculovirus
Research on baculovirus described by scientists at University of Otago, Medical Department - Cytomegalovirus
New cytomegalovirus study findings have been reported by scientists at University of Oxford - DNA Vaccines
New DNA vaccines study findings have been published by scientists at Autonomous University - DNA Vaccines
Research on DNA vaccines detailed by H. Garren and co-authors - More from this issue of Vaccine Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
